IMATINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
11752MMP | IMATINIB imatinib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 5 | $289.69 | $31.60 | $31.60 |
Available brands | |||||||
Gilmata | |||||||
Gliveca | |||||||
IMATINIB RBXa | |||||||
Imaniba | |||||||
Imatinib Sandoza | |||||||
Imatinib-Tevaa |
IMATINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
11758WMP | IMATINIB imatinib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 5 | $289.69 | $31.60 | $31.60 |
Available brands | |||||||
Gilmata | |||||||
Gliveca | |||||||
IMATINIB RBXa | |||||||
Imaniba | |||||||
Imatinib Sandoza | |||||||
Imatinib-Tevaa |
IMATINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
11765FMP | IMATINIB imatinib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 5 | $289.69 | $31.60 | $31.60 |
Available brands | |||||||
Gilmata | |||||||
Gliveca | |||||||
IMATINIB RBXa | |||||||
Imaniba | |||||||
Imatinib Sandoza | |||||||
Imatinib-Tevaa |
IMATINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
11778XMP | IMATINIB imatinib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 2 | $289.69 | $31.60 | $31.60 |
Available brands | |||||||
Gilmata | |||||||
Gliveca | |||||||
IMATINIB RBXa | |||||||
Imaniba | |||||||
Imatinib Sandoza | |||||||
Imatinib-Tevaa |
IMATINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
11785GMP | IMATINIB imatinib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 5 | $289.69 | $31.60 | $31.60 |
Available brands | |||||||
Gilmata | |||||||
Gliveca | |||||||
IMATINIB RBXa | |||||||
Imaniba | |||||||
Imatinib Sandoza | |||||||
Imatinib-Tevaa |
IMATINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
11786HMP | IMATINIB imatinib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 5 | $289.69 | $31.60 | $31.60 |
Available brands | |||||||
Gilmata | |||||||
Gliveca | |||||||
IMATINIB RBXa | |||||||
Imaniba | |||||||
Imatinib Sandoza | |||||||
Imatinib-Tevaa |
IMATINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
11788KMP | IMATINIB imatinib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 5 | $289.69 | $31.60 | $31.60 |
Available brands | |||||||
Gilmata | |||||||
Gliveca | |||||||
IMATINIB RBXa | |||||||
Imaniba | |||||||
Imatinib Sandoza | |||||||
Imatinib-Tevaa |
IMATINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
11789LMP | IMATINIB imatinib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 2 | $289.69 | $31.60 | $31.60 |
Available brands | |||||||
Gilmata | |||||||
Gliveca | |||||||
IMATINIB RBXa | |||||||
Imaniba | |||||||
Imatinib Sandoza | |||||||
Imatinib-Tevaa |
IMATINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
11878EMP | IMATINIB imatinib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 2 | $289.69 | $31.60 | $31.60 |
Available brands | |||||||
Gilmata | |||||||
Gliveca | |||||||
IMATINIB RBXa | |||||||
Imaniba | |||||||
Imatinib Sandoza | |||||||
Imatinib-Tevaa |
IMATINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
5444MMP | IMATINIB imatinib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 5 | $289.69 | $31.60 | $31.60 |
Available brands | |||||||
Gilmata | |||||||
Gliveca | |||||||
IMATINIB RBXa | |||||||
Imaniba | |||||||
Imatinib Sandoza | |||||||
Imatinib-Tevaa |
IMATINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
9112NMP | IMATINIB imatinib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 2 | $289.69 | $31.60 | $31.60 |
Available brands | |||||||
Gilmata | |||||||
Gliveca | |||||||
IMATINIB RBXa | |||||||
Imaniba | |||||||
Imatinib Sandoza | |||||||
Imatinib-Tevaa |
IMATINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
9114QMP | IMATINIB imatinib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 5 | $289.69 | $31.60 | $31.60 |
Available brands | |||||||
Gilmata | |||||||
Gliveca | |||||||
IMATINIB RBXa | |||||||
Imaniba | |||||||
Imatinib Sandoza | |||||||
Imatinib-Tevaa |
IMATINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
9116TMP | IMATINIB imatinib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 2 | $289.69 | $31.60 | $31.60 |
Available brands | |||||||
Gilmata | |||||||
Gliveca | |||||||
IMATINIB RBXa | |||||||
Imaniba | |||||||
Imatinib Sandoza | |||||||
Imatinib-Tevaa |
IMATINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
9124FMP | IMATINIB imatinib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 2 | $289.69 | $31.60 | $31.60 |
Available brands | |||||||
Gilmata | |||||||
Gliveca | |||||||
IMATINIB RBXa | |||||||
Imaniba | |||||||
Imatinib Sandoza | |||||||
Imatinib-Tevaa |
IMATINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
9173TMP | IMATINIB imatinib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 5 | $289.69 | $31.60 | $31.60 |
Available brands | |||||||
Gilmata | |||||||
Gliveca | |||||||
IMATINIB RBXa | |||||||
Imaniba | |||||||
Imatinib Sandoza | |||||||
Imatinib-Tevaa |
IMATINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
9175XMP | IMATINIB imatinib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 5 | $289.69 | $31.60 | $31.60 |
Available brands | |||||||
Gilmata | |||||||
Gliveca | |||||||
IMATINIB RBXa | |||||||
Imaniba | |||||||
Imatinib Sandoza | |||||||
Imatinib-Tevaa |
IMATINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
9177BMP | IMATINIB imatinib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 5 | $289.69 | $31.60 | $31.60 |
Available brands | |||||||
Gilmata | |||||||
Gliveca | |||||||
IMATINIB RBXa | |||||||
Imaniba | |||||||
Imatinib Sandoza | |||||||
Imatinib-Tevaa |
IMATINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
9179DMP | IMATINIB imatinib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 5 | $289.69 | $31.60 | $31.60 |
Available brands | |||||||
Gilmata | |||||||
Gliveca | |||||||
IMATINIB RBXa | |||||||
Imaniba | |||||||
Imatinib Sandoza | |||||||
Imatinib-Tevaa |
- Legend
- aBrand equivalent a
- MPMedical Practitioner